IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 360 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 1.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,257,801 | +9.1% | 292,473 | -1.2% | 0.16% | +23.4% |
| Q2 2023 | $12,147,335 | +23.5% | 296,132 | -0.4% | 0.13% | +13.3% |
| Q1 2023 | $9,834,325 | -22.6% | 297,469 | -11.7% | 0.11% | -38.3% |
| Q4 2022 | $12,711,633 | -20.5% | 336,732 | -23.0% | 0.18% | -10.3% |
| Q3 2022 | $15,983,000 | +3.5% | 437,176 | -6.6% | 0.20% | +6.8% |
| Q2 2022 | $15,448,000 | -28.1% | 468,116 | -21.9% | 0.19% | +20.9% |
| Q1 2022 | $21,490,000 | +19.8% | 599,616 | -1.0% | 0.16% | +68.1% |
| Q4 2021 | $17,935,000 | -20.7% | 605,902 | -10.3% | 0.09% | -3.1% |
| Q3 2021 | $22,623,000 | +11.0% | 675,301 | +32.8% | 0.10% | +21.2% |
| Q2 2021 | $20,381,000 | -9.0% | 508,374 | +2.0% | 0.08% | -27.3% |
| Q1 2021 | $22,402,000 | +22.6% | 498,256 | +54.2% | 0.11% | +5.8% |
| Q4 2020 | $18,272,000 | +70.0% | 323,168 | +41.9% | 0.10% | +9.5% |
| Q3 2020 | $10,746,000 | -24.7% | 227,667 | -7.8% | 0.10% | -49.2% |
| Q2 2020 | $14,272,000 | -60.4% | 246,919 | -67.6% | 0.19% | -44.7% |
| Q1 2020 | $36,038,000 | +40.5% | 762,224 | +79.5% | 0.34% | -16.3% |
| Q4 2019 | $25,655,000 | +17.6% | 424,683 | +16.6% | 0.40% | +4.1% |
| Q3 2019 | $21,813,000 | +10.2% | 364,091 | +18.2% | 0.39% | 0.0% |
| Q2 2019 | $19,795,000 | +35.8% | 308,002 | +71.6% | 0.39% | +1.0% |
| Q1 2019 | $14,573,000 | – | 179,533 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
| M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
| Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
| Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
| BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
| Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
| Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
| Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
| Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
| SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |